Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 14
2004 22
2005 21
2006 17
2007 11
2008 10
2009 10
2010 19
2011 41
2012 61
2013 34
2014 33
2015 30
2016 33
2017 27
2018 30
2019 25
2020 28
2021 21
2022 11
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Trials of Stem Cell Treatment for Spinal Cord Injury.
Yamazaki K, Kawabori M, Seki T, Houkin K. Yamazaki K, et al. Among authors: houkin k. Int J Mol Sci. 2020 Jun 2;21(11):3994. doi: 10.3390/ijms21113994. Int J Mol Sci. 2020. PMID: 32498423 Free PMC article. Review.
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K; CSPS.com Trial Investigators. Toyoda K, et al. Among authors: houkin k. Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6. Lancet Neurol. 2019. PMID: 31122494 Clinical Trial.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Among authors: houkin k. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
Suprasellar hemangioblastoma.
Miyata S, Mikami T, Minamida Y, Akiyama Y, Houkin K. Miyata S, et al. Among authors: houkin k. J Neuroophthalmol. 2008 Dec;28(4):325-6. doi: 10.1097/WNO.0b013e318183c633. J Neuroophthalmol. 2008. PMID: 19145134
Usefulness of FMISO-PET for glioma analysis.
Kobayashi H, Hirata K, Yamaguchi S, Terasaka S, Shiga T, Houkin K. Kobayashi H, et al. Among authors: houkin k. Neurol Med Chir (Tokyo). 2013;53(11):773-8. doi: 10.2176/nmc.ra2013-0256. Epub 2013 Oct 29. Neurol Med Chir (Tokyo). 2013. PMID: 24172591 Free PMC article. Review.
[Surgery for unruptured anterior cerebral artery aneurysms].
Sugiyama T, Houkin K, Ito M, Hokari M, Nakayama N, Kazumata K, Kuroda S. Sugiyama T, et al. Among authors: houkin k. No Shinkei Geka. 2012 Jun;40(6):555-65. No Shinkei Geka. 2012. PMID: 22647516 Review. Japanese.
Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.
Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction. Houkin K, et al. Stroke. 2018 Apr;49(4):e145-e152. doi: 10.1161/STROKEAHA.117.019216. Epub 2018 Mar 16. Stroke. 2018. PMID: 29581346 Review. No abstract available.
429 results